Rockville’s Immunomic Therapeutics Inc. is on track to go public later this year, after Covid-19 threw a wrench in the vaccine maker’s initial timeline. But a few things must happen first. So while juggling clinical trials, the immunotherapy company is hiring aggressively, expanding its Montgomery County footprint and eyeing more funding ahead of an initial public offering slated for the second half of this year.
Exclusive: Rockville biotech expanding, ‘on the prowl’ for talent ahead of planned IPO
March 18, 2022